Opinion|Videos|October 21, 2024
Expectations for PFS and OS in Relapsed/Refractory SCLC
Author(s)Joshua K. Sabari, MD
Joshua K. Sabari, MD, discusses the expected PFS of 3 to 6 months and OS of 6 to 12 months for second- or third-line therapy in previously treated patients with relapsed/refractory SCLC.
Episodes in this series
Video content above is prompted by the following:
What PFS and OS end points would you typically expect from second- or third-line therapy in your previously treated patients with relapsed/refractory SCLC?
